Alireza Gheflati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alireza Gheflati has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Saeid Hadi
Nutrition and Food Health Research Center AJA University of Medical Sciences Tehran Iran
2 shared publicationsAfsaneh Salari
Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publicationAli Jafarzadeh Esfehani
Metabolic Syndrome Research Center Mashhad University of Medical Sciences Mashhad Iran
1 shared publicationAmir Hossein Mansouri
Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad 91357-345, Iran
1 shared publication- Asma Afshari
Department of Nutrition, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication Ebrahim Hazrati
Departemnt of Anesthesiology and Intensive Care, Medical Faculty AJA University of Medical Sciences Tehran Iran
1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (8) , e70162
The Effects of Bromelain Supplementation on Clinical Outcomes, Inflammatory and Oxidative Stress Biomarkers in Patients With Traumatic Brain Injury: A Randomized, Double‐Blind Placebo‐Controlled Clinical Trial
Traumatic brain injury (TBI) is the leading cause of death from injury. Many studies have shown that cytokines, chemokines, and oxidative stress play a crucial role in the pathophysiology of TBI. One of the types of interventions that are receiving more and more attention is nutritional support and the use of nutritional supplements to reduce inflammation in these patients. The present study was a double‐blind controlled clinical trial, performed on patients with traumatic brain injury. Patients in the intervention group received 600 mg of oral bromelain daily through gavage, while the patients in the control group received a placebo for 14 days. SOFA, APACHE, and NUTRIC scores were evaluated at each time of blood sampling and 28‐ and 60‐day mortality. Also, clinical and biochemical information (CRP, MDA, IL‐6, and TAC), anthropometry, and nutritional information of patients were recorded during the study. There was no significant difference between the two groups in terms of gender, weight, BMI, MAC, APACHE SCORE, NUTRIC SCORE, SOFA SCORE, and energy intake at the beginning of the study ( p > 0.05). Bromelain supplementation significantly reduced IL‐6 levels ( p < 0.001), APACHE score ( p = 0.011), SOFA score ( p < 0.001), and NUTRIC score ( p < 0.001). Furthermore, 60‐day mortality was significantly lower in the bromelain group compared to the placebo group ( p = 0.036). However, there was no significant effect on CRP ( p = 0.377), MDA ( p = 0.061), TAC levels ( p = 0.185). Bromelain supplementation significantly improved IL‐6 levels, APACHE, SOFA, and NUTRIC scores, and reduced 60‐day mortality in patients with traumatic brain injury. However, its effects on CRP, MDA and TAC levels were not statistically significant. These findings suggest that bromelain may serve as a promising adjunctive therapy to reduce inflammation and improve clinical outcomes in critically ill TBI patients. Further studies with larger sample sizes and longer follow‐up periods are needed to confirm these results.
- 29 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (8) , e70162
Open AccessThe Effects of Bromelain Supplementation on Clinical Outcomes, Inflammatory and Oxidative Stress Biomarkers in Patients With Traumatic Brain Injury: A Randomized, Double‐Blind Placebo‐Controlled Clinical Trial
Traumatic brain injury (TBI) is the leading cause of death from injury. Many studies have shown that cytokines, chemokines, and oxidative stress play a crucial role in the pathophysiology of TBI. One of the types of interventions that are receiving more and more attention is nutritional support and the use of nutritional supplements to reduce inflammation in these patients. The present study was a double‐blind controlled clinical trial, performed on patients with traumatic brain injury. Patients in the intervention group received 600 mg of oral bromelain daily through gavage, while the patients in the control group received a placebo for 14 days. SOFA, APACHE, and NUTRIC scores were evaluated at each time of blood sampling and 28‐ and 60‐day mortality. Also, clinical and biochemical information (CRP, MDA, IL‐6, and TAC), anthropometry, and nutritional information of patients were recorded during the study. There was no significant difference between the two groups in terms of gender, weight, BMI, MAC, APACHE SCORE, NUTRIC SCORE, SOFA SCORE, and energy intake at the beginning of the study ( p > 0.05). Bromelain supplementation significantly reduced IL‐6 levels ( p < 0.001), APACHE score ( p = 0.011), SOFA score ( p < 0.001), and NUTRIC score ( p < 0.001). Furthermore, 60‐day mortality was significantly lower in the bromelain group compared to the placebo group ( p = 0.036). However, there was no significant effect on CRP ( p = 0.377), MDA ( p = 0.061), TAC levels ( p = 0.185). Bromelain supplementation significantly improved IL‐6 levels, APACHE, SOFA, and NUTRIC scores, and reduced 60‐day mortality in patients with traumatic brain injury. However, its effects on CRP, MDA and TAC levels were not statistically significant. These findings suggest that bromelain may serve as a promising adjunctive therapy to reduce inflammation and improve clinical outcomes in critically ill TBI patients. Further studies with larger sample sizes and longer follow‐up periods are needed to confirm these results.
- Open Access
- 1 January 2025
- Published by Korean Society of Clinical Nutrition in Clinical Nutrition Research
- Vol. 14 (3) , 230-240
Effects of Vaccinium meridionale Swartz (agraz) Supplementation on Inflammatory and Oxidative Stress Markers in Patients With Metabolic Syndrome: A Systematic Review of Randomized Controlled Clinical Trials
Mashhour ZM, et al. Clin Nutr Res. 2025 Jul;14(3):230-240. https://doi.org/10.7762/cnr.2025.14.3.230
- 1 January 2025
- Published by Korean Society of Clinical Nutrition in Clinical Nutrition Research
- Vol. 14 (3) , 230-240
Open AccessEffects of Vaccinium meridionale Swartz (agraz) Supplementation on Inflammatory and Oxidative Stress Markers in Patients With Metabolic Syndrome: A Systematic Review of Randomized Controlled Clinical Trials
Mashhour ZM, et al. Clin Nutr Res. 2025 Jul;14(3):230-240. https://doi.org/10.7762/cnr.2025.14.3.230
- Open Access
- 6 October 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (10) , e70019
Effects of zinc supplementation on sleep quality in humans: A systematic review of randomized controlled trials
Background and Aims: Alternative therapies, such as zinc supplementation, have been explored as potential interventions for sleep disorders. However, the efficacy of zinc supplementation in improving sleep quality remains uncertain. This systematic review aims to examine the impacts of zinc supplementation on sleep quality in humans.Methods: The Web of Science, Medline, Scopus, and Google Scholar databases were comprehensively searched to find studies investigating the effect of zinc supplementation on sleep quality. After identifying relevant studies by screening, relevant data were extracted from them. The quality assessment was conducted using the Cochrane quality assessment tool.Results: This systematic review included eight studies. The interventions ranged from 4 to 48 weeks, with a daily dose of zinc supplementation varying between 10 and 73.3 mg. The majority of the evidence examined in this review pointed to the significant improvement effect of zinc supplementation on sleep quality in adults compared to the control groups. Furthermore, zinc supplementation did not have a significant effect on sleep disorders. However, there was no consensus about these findings. Also, the effect of supplementation on sleep duration in nonadults was contradictory.Conclusions: This systematic review suggests that zinc supplementation may lead to improvements in sleep quality. However, more research, primarily clinical trials, is needed to clarify the beneficial effects of zinc supplementation on sleep quality with consideration of dietary zinc intake and the Recommended Dietary Allowances of zinc (RDA) in the different populations. It is also recommended to investigate the effect of zinc supplementation on sleep quality in people with zinc deficiency in future studies.
- 6 October 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (10) , e70019
Open AccessEffects of zinc supplementation on sleep quality in humans: A systematic review of randomized controlled trials
Background and Aims: Alternative therapies, such as zinc supplementation, have been explored as potential interventions for sleep disorders. However, the efficacy of zinc supplementation in improving sleep quality remains uncertain. This systematic review aims to examine the impacts of zinc supplementation on sleep quality in humans.Methods: The Web of Science, Medline, Scopus, and Google Scholar databases were comprehensively searched to find studies investigating the effect of zinc supplementation on sleep quality. After identifying relevant studies by screening, relevant data were extracted from them. The quality assessment was conducted using the Cochrane quality assessment tool.Results: This systematic review included eight studies. The interventions ranged from 4 to 48 weeks, with a daily dose of zinc supplementation varying between 10 and 73.3 mg. The majority of the evidence examined in this review pointed to the significant improvement effect of zinc supplementation on sleep quality in adults compared to the control groups. Furthermore, zinc supplementation did not have a significant effect on sleep disorders. However, there was no consensus about these findings. Also, the effect of supplementation on sleep duration in nonadults was contradictory.Conclusions: This systematic review suggests that zinc supplementation may lead to improvements in sleep quality. However, more research, primarily clinical trials, is needed to clarify the beneficial effects of zinc supplementation on sleep quality with consideration of dietary zinc intake and the Recommended Dietary Allowances of zinc (RDA) in the different populations. It is also recommended to investigate the effect of zinc supplementation on sleep quality in people with zinc deficiency in future studies.